B&S Group.

bnsgroup.co.uk

The B & S Group is a growing and innovative distributor and manufacturer serving the UK pharmaceutical market. We are dedicated to the import, sales, manufacturing and distribution of high quality pharmaceutical and healthcare products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

KUBOTA PHARMACEUTICAL HOLDINGS SIGNS LETTER OF INTENT TO FORM A JOINT VENTURE WITH SBI HOLDINGS

Pharmaceutical | December 26, 2016

news image

Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596, “Kubota Pharma”), a clinical-stage ophthalmology company committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide, and SBI Holdings, Inc. (“SBI”), a financial services and asset management company based in Japan, announced today the signing of a non-binding letter of intent (“LOI”) to establish a joint venture that will organize and manage special purpose...

Read More

CMA DISCOVERS MORE PHARMACEUTICAL FUNNY BUSINESS

CMA | December 16, 2016

news image

Just a week after fining two drug companies £90m, the Competition & Markets Authority has unearthed yet more pharmaceutical funny business. This time it involves a life-saving treatment, hydrocorisone, that is used to treat people whose adrenal glands don’t produce sufficient amounts of natural steroid hormones…...

Read More

SIX BIG PHARMACEUTICAL COMPANIES ACCUSED OF PRICE FIXING

ZME Science | December 21, 2016

news image

US authorities have charged six companies of price fixing in the US, India, and Australia. Drugmakers Mylan, Heritage Pharmaceuticals, Teva Pharmaceutical USA and Citron Pharma are named in the lawsuit alongside India’s Aurobindo Pharma and Australia’s Mayne Pharmaceuticals....

Read More

SUN PHARMA & ICGEB ANNOUNCE NEW EXCLUSIVE COLLABORATION TO DEVELOP NOVEL DENGUE VACCINE FOR INDIA & GLOBAL MARKETS

SUN PHARMA | October 19, 2016

news image

International Centre for Genetic Engineering and Biotechnology (ICGEB) and Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today announced their new collaboration for development of a dengue vaccine, targeted against all the four serotypes of Dengue virus that cause disease in humans....

Read More
news image

KUBOTA PHARMACEUTICAL HOLDINGS SIGNS LETTER OF INTENT TO FORM A JOINT VENTURE WITH SBI HOLDINGS

Pharmaceutical | December 26, 2016

Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596, “Kubota Pharma”), a clinical-stage ophthalmology company committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide, and SBI Holdings, Inc. (“SBI”), a financial services and asset management company based in Japan, announced today the signing of a non-binding letter of intent (“LOI”) to establish a joint venture that will organize and manage special purpose...

Read More
news image

CMA DISCOVERS MORE PHARMACEUTICAL FUNNY BUSINESS

CMA | December 16, 2016

Just a week after fining two drug companies £90m, the Competition & Markets Authority has unearthed yet more pharmaceutical funny business. This time it involves a life-saving treatment, hydrocorisone, that is used to treat people whose adrenal glands don’t produce sufficient amounts of natural steroid hormones…...

Read More
news image

SIX BIG PHARMACEUTICAL COMPANIES ACCUSED OF PRICE FIXING

ZME Science | December 21, 2016

US authorities have charged six companies of price fixing in the US, India, and Australia. Drugmakers Mylan, Heritage Pharmaceuticals, Teva Pharmaceutical USA and Citron Pharma are named in the lawsuit alongside India’s Aurobindo Pharma and Australia’s Mayne Pharmaceuticals....

Read More
news image

SUN PHARMA & ICGEB ANNOUNCE NEW EXCLUSIVE COLLABORATION TO DEVELOP NOVEL DENGUE VACCINE FOR INDIA & GLOBAL MARKETS

SUN PHARMA | October 19, 2016

International Centre for Genetic Engineering and Biotechnology (ICGEB) and Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today announced their new collaboration for development of a dengue vaccine, targeted against all the four serotypes of Dengue virus that cause disease in humans....

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us